Blood products: distribution, supply and dispensing
This section provides information for health professionals regarding the distribution, supply and dispensing of fractionated blood products (purified plasma protein derivatives).
Policies, guidelines and forms
- This policy outlines the systems within NZBS for dispensing medicines in a manner that complies with the requirements of the Medicines Act 1981 and the Medicines Regulations 1984.
-
Dispensing of Interchangeable Blood Products (111D003) (PDF, 91 KB)
- This policy statement sets out the role of the Manufacturers, NZBS and Users who require fractionated (purified processed) plasma products, or recombinant coagulation factor concentrates that are available through NZBS.
- This information document about blood components describes the maximum time intervals and required handling conditions between issuing from a Blood Bank and completion of transfusion, or return to a Blood Bank.
-
CSL Product Complaint Process Flowchart (111D135) (PDF, 94 KB)
The process is described for notifying NZBS of any adverse reactions to blood products manufactured by CSL or other manufacturers.
You may need to download Adobe Reader to view the PDF files. It is available free from the Adobe site.
